ADMA insider transactions
ADMA Biologics Inc (ADMA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ADMA
- Director Grossman Jerrold B bought $50,624 worth of shares (6,400 units at $7.91), increasing direct ownership by 1% to 520,284 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Grossman Jerrold B bought $100,125 worth of shares (12,500 units at $8.01), increasing direct ownership by 2% to 513,884 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Grossman Jerrold B bought $100,125 worth of shares (12,500 units at $8.01), increasing direct ownership by 3% to 501,384 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- SEC Form 4 filed by Kestenberg-Messina Kaitlin M.4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Guiheen Lawrence P. exercised 30,000 shares at a strike of $3.66, gifted 30,000 shares and received a gift of 30,000 shares (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S exercised 15,000 shares at a strike of $5.40 and sold $318,360 worth of shares (21,000 units at $15.16), decreasing direct ownership by 0.28% to 2,112,777 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- SEC Form 4 filed by ADMA Biologics Inc4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S covered exercise/tax liability with 85,951 shares, decreasing direct ownership by 4% to 2,118,777 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Elms Steve bought $217,420 worth of shares (14,000 units at $15.53) (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S covered exercise/tax liability with 54,858 shares, decreasing direct ownership by 2% to 2,204,728 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- New insider Kohler Terry claimed ownership of 58,019 shares (SEC Form 3)3 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- COO and SVP, Compliance Kestenberg-Messina Kaitlin M. covered exercise/tax liability with 8,161 shares, decreasing direct ownership by 1% to 572,160 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S covered exercise/tax liability with 24,793 shares, decreasing direct ownership by 1% to 2,259,586 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- CFO and Treasurer Tade Brad L. covered exercise/tax liability with 6,479 shares, decreasing direct ownership by 3% to 232,940 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S exercised 15,000 shares at a strike of $5.40 and sold $337,680 worth of shares (21,000 units at $16.08), decreasing direct ownership by 0.26% to 2,284,379 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- COO and SVP, Compliance Kestenberg-Messina Kaitlin M. was granted 91,631 shares, increasing direct ownership by 19% to 580,321 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Grossman Jerrold B was granted 10,690 shares, increasing direct ownership by 2% to 488,884 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Finger Alison Cecily was granted 10,690 shares, increasing direct ownership by 31% to 45,619 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Kwon Young was granted 10,690 shares, increasing direct ownership by 4% to 263,020 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Guiheen Lawrence P. was granted 10,690 shares, increasing direct ownership by 11% to 105,520 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S was granted 282,529 shares, increasing direct ownership by 14% to 2,290,379 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Salas Eduardo Rene was granted 10,690 shares, increasing direct ownership by 98% to 21,579 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Elms Steve was granted 10,690 shares, increasing direct ownership by 12% to 98,020 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S exercised 15,000 shares at a strike of $5.40 and sold $415,590 worth of shares (21,000 units at $19.79), decreasing direct ownership by 0.30% to 2,007,850 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S exercised 15,000 shares at a strike of $5.40 and sold $336,000 worth of shares (21,000 units at $16.00), decreasing direct ownership by 0.30% to 2,013,850 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S exercised 15,000 shares at a strike of $5.40 and sold $336,000 worth of shares (21,000 units at $16.00), decreasing direct ownership by 0.30% to 2,019,850 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S exercised 15,000 shares at a strike of $5.40 and sold $338,730 worth of shares (21,000 units at $16.13), decreasing direct ownership by 0.30% to 2,025,850 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S exercised 15,000 shares at a strike of $5.40 and sold $354,480 worth of shares (21,000 units at $16.88), decreasing direct ownership by 0.29% to 2,031,850 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- COO and SVP, Compliance Kestenberg-Messina Kaitlin M. exercised 2,500 shares at a strike of $8.98 and covered exercise/tax liability with 1,208 shares, increasing direct ownership by 0.27% to 488,690 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- COO and SVP, Compliance Kestenberg-Messina Kaitlin M. covered exercise/tax liability with 3,027 shares, decreasing direct ownership by 0.62% to 487,398 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- CFO and Treasurer Tade Brad L. covered exercise/tax liability with 7,123 shares, decreasing direct ownership by 3% to 239,419 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S exercised 15,000 shares at a strike of $5.40 and sold $391,860 worth of shares (21,000 units at $18.66), decreasing direct ownership by 0.29% to 2,037,850 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- CFO and Treasurer Tade Brad L. covered exercise/tax liability with 9,838 shares, decreasing direct ownership by 4% to 246,542 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S exercised 15,000 shares at a strike of $5.40 and sold $437,010 worth of shares (21,000 units at $20.81), decreasing direct ownership by 0.29% to 2,043,850 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Elms Steve sold $8,829,333 worth of shares (425,621 units at $20.74) and exercised 332,680 shares at a strike of $3.43 (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Guiheen Lawrence P. sold $419,200 worth of shares (20,000 units at $20.96), decreasing direct ownership by 17% to 94,830 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Grossman Jerrold B exercised 10,000 shares at a strike of $5.00 and sold $213,100 worth of shares (10,000 units at $21.31) (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Guiheen Lawrence P. exercised 9,000 shares at a strike of $5.96 and sold $182,636 worth of shares (9,000 units at $20.29) (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S sold $408,450 worth of shares (21,000 units at $19.45) and exercised 15,000 shares at a strike of $5.40, decreasing direct ownership by 0.29% to 2,049,850 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S exercised 15,000 shares at a strike of $5.40 and sold $450,660 worth of shares (21,000 units at $21.46), decreasing direct ownership by 0.29% to 2,055,850 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- COO and SVP, Compliance Kestenberg-Messina Kaitlin M. covered exercise/tax liability with 18,920 shares, decreasing direct ownership by 4% to 490,425 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S exercised 15,000 shares at a strike of $5.40 and sold $397,320 worth of shares (21,000 units at $18.92), decreasing direct ownership by 0.29% to 2,061,850 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S covered exercise/tax liability with 85,951 shares, decreasing direct ownership by 4% to 2,067,850 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- COO and SVP, Compliance Kestenberg-Messina Kaitlin M. covered exercise/tax liability with 12,816 shares, decreasing direct ownership by 2% to 509,345 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S covered exercise/tax liability with 72,885 shares, decreasing direct ownership by 3% to 2,153,801 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- COO and SVP, Compliance Kestenberg-Messina Kaitlin M. covered exercise/tax liability with 1,855 shares, decreasing direct ownership by 0.35% to 522,161 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- CFO and Treasurer Tade Brad L. covered exercise/tax liability with 5,280 shares, decreasing direct ownership by 2% to 256,380 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Salas Eduardo Rene was granted 10,889 shares (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Guiheen Lawrence P. was granted 10,889 shares, increasing direct ownership by 7% to 164,830 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Kwon Young gave a grant of 10,889 shares, decreasing direct ownership by 4% to 252,330 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Elms Steve was granted 10,889 shares, increasing direct ownership by 14% to 87,330 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Grossman Jerrold B was granted 10,889 shares, increasing direct ownership by 2% to 478,194 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- Director Finger Alison Cecily was granted 10,889 shares, increasing direct ownership by 45% to 34,929 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- COO and SVP, Compliance Kestenberg-Messina Kaitlin M. was granted 77,784 shares, increasing direct ownership by 17% to 524,016 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- CFO and Treasurer Tade Brad L. was granted 62,227 shares, increasing direct ownership by 31% to 261,660 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S was granted 252,022 shares, increasing direct ownership by 13% to 2,226,686 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- COO and SVP, Compliance Kestenberg-Messina Kaitlin M. exercised 5,000 shares at a strike of $10.80 and covered exercise/tax liability with 3,355 shares, increasing direct ownership by 0.37% to 446,232 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- COO and SVP, Compliance Kestenberg-Messina Kaitlin M. covered exercise/tax liability with 1,854 shares, decreasing direct ownership by 0.42% to 444,587 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- President and CEO Grossman Adam S covered exercise/tax liability with 14,343 shares, decreasing direct ownership by 0.72% to 1,974,664 units (SEC Form 4)4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)
- SEC Form 4 filed by Director Salas Eduardo Rene4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)